SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Eisai Co., Ltd. ESAIY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Eisai Co., Ltd. (ESAIY) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $7.71. It has a SharesGrow Score of 76/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $789.4B, +1.5%/yr average growth. Net income is $46.4B, growing at +0.5%/yr. Net profit margin is 5.9% (thin). Gross margin is 78.6% (+1.7 pp trend).

Balance sheet: total debt is $187.5B against $841.4B equity (Debt-to-Equity (D/E) ratio 0.22, conservative). Current ratio is 1.95 (strong liquidity). Debt-to-assets is 13.5%. Total assets: $1.4T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 45/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 78/100 (Pass), Future ?/100 (Fail), Income 45/100 (Partial).

ESAIY SharesGrow Score Overview

78/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 45/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 78/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ESAIY

ESAIY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ESAIY: +1.5%/yr revenue is, +0.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ESAIY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ESAIY: Debt-to-Equity (D/E) ratio 0.22 (conservative), Current ratio is 1.95 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

ESAIY: Gross margin is 78.6% (+1.7 pp trend), $9B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 78/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

ESAIY: Net profit margin is 5.9%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range5.94-9.22

Volume990

Avg Volume (30D)83.07K

Market Cap$8.79B

Beta (1Y)-0.10

Dividend Yield$0.1010

Share Statistics

EPS (TTM)40.94

Shares Outstanding$1.13B

IPO Date2023-02-02

Employees11,067

CEOHaruo Naito

Financial Highlights & Ratios

Revenue (TTM)$789.4B

Gross Profit$620.59B

EBITDA$104.49B

Net Income$46.43B

Operating Income$54.38B

Total Cash$266.05B

Total Debt$187.52B

Net Debt$-78.04B

Total Assets$1.39T

Price / Earnings (P/E)0.2

Price / Sales (P/S)0.01

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINUS28258A1079

Price Chart

ESAIY

Eisai Co., Ltd. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

5.94 52WK RANGE 9.22

People Also View

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message